These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2461620)

  • 1. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effectiveness of barucainide in supraventriculr and ventricular arrhythmias].
    Brugger P
    Z Kardiol; 1989 Aug; 78(8):510-8. PubMed ID: 2477959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
    Scheininger M; Dziersk J; Kullak W; Kors A; Köhler JA; Theisen K
    Z Kardiol; 1991 Oct; 80(10):630-6. PubMed ID: 1722935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 8. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochloride.
    Chiladakis I; Hindricks G; Haverkamp W; Vogt J; Gülker H
    Arzneimittelforschung; 1989 Sep; 39(9):1130-2. PubMed ID: 2590263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dose-related effect of nicainoprol (CAS 924) on basic electrophysiologic parameters in patients with and without diseases of the heart conduction system].
    Sen S; Rettig G; Schieffer H; Bette L
    Z Kardiol; 1988 Sep; 77(9):600-7. PubMed ID: 3195179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of chronic ventricular arrhythmia].
    Motté G; Slama M; Dinanian S; Sebag C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():85-9. PubMed ID: 1284883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pentisomide on stable ventricular premature beats. Comparison with placebo.
    Mangini SG; Mastropasqua F; Oldani V; Massari F; Maino GN; Ricci A; Scrutinio D; Rizzon P
    Eur Heart J; 1991 Jun; 12(6):712-9. PubMed ID: 1713557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine as an antiarrhythmic Experience in 68 patients.
    Flensted-Jensen E; Sandoe E
    Acta Med Scand; 1969 Apr; 185(4):297-302. PubMed ID: 4185142
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Sep; 77(9):595-9. PubMed ID: 3195178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamics in ventricular arrhythmias and in their treatment].
    Lüderitz B; Manz M
    Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.